Olema Pharmaceuticals (OLMA) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free OLMA Stock Alerts $9.84 +0.18 (+1.86%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Olema Pharmaceuticals Short Interest DataCurrent Short Volume8,400,000 sharesPrevious Short Volume8,970,000 sharesChange Vs. Previous Month-6.35%Dollar Volume Sold Short$85.43 millionShort Interest Ratio / Days to Cover10.5Last Record DateApril 30, 2024Outstanding Shares55,930,000 sharesPercentage of Shares Shorted15.02%Today's Trading Volume547,955 sharesAverage Trading Volume786,233 sharesToday's Volume Vs. Average70% Short Selling Olema Pharmaceuticals ? Sign up to receive the latest short interest report for Olema Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOLMA Short Interest Over TimeOLMA Days to Cover Over TimeOLMA Percentage of Float Shorted Over Time Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. Olema Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20248,400,000 shares $85.43 million -6.4%N/A10.5 $10.17 4/15/20248,970,000 shares $97.32 million +10.7%N/A11.1 $10.85 3/31/20248,100,000 shares $91.69 million +60.1%N/A9.9 $11.32 3/15/20245,060,000 shares $58.44 million +3.9%N/A6.4 $11.55 2/29/20244,870,000 shares $60.39 million -21.2%N/A5.9 $12.40 2/15/20246,180,000 shares $91.53 million -7.9%N/A6.8 $14.81 Get the Latest News and Ratings for OLMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Olema Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20246,710,000 shares $87.50 million -5.2%N/A7.5 $13.04 1/15/20247,080,000 shares $82.13 million +0.7%N/A8.3 $11.60 12/31/20237,030,000 shares $98.63 million +5.7%N/A8.5 $14.03 12/15/20236,650,000 shares $81.13 million +27.6%N/A8.5 $12.20 11/30/20235,210,000 shares $72.68 million +88.8%N/A8.1 $13.95 11/15/20232,760,000 shares $46.42 million No ChangeN/A6.4 $16.82 10/31/20232,760,000 shares $36.68 million +26.0%7.3%7.9 $13.29 10/15/20232,190,000 shares $27.66 million +10.6%5.8%7.6 $12.63 9/30/20231,980,000 shares $24.45 million +12.5%5.4%7.1 $12.35 9/15/20231,760,000 shares $22.69 million +10.7%4.8%5.9 $12.89 8/31/20231,590,000 shares $16.14 million -9.7%4.4%4.1 $10.15 8/15/20231,760,000 shares $19.03 million -4.4%5.0%4.8 $10.81 7/31/20231,840,000 shares $15.92 million -4.7%5.3%5.1 $8.65 7/15/20231,930,000 shares $15.81 million +5.5%5.6%5.4 $8.19 6/30/20231,830,000 shares $16.52 million +55.1%5.3%5 $9.03 6/15/20231,180,000 shares $10.71 million +14.6%3.4%3.7 $9.08 5/31/20231,030,000 shares $5.33 million No Change3.0%5.2 $5.17 5/15/20231,030,000 shares $6.89 million +1.0%3.0%6.2 $6.69 4/30/20231,020,000 shares $4.89 million -6.4%3.0%6 $4.79 4/15/20231,090,000 shares $3.99 million -4.4%3.2%6.5 $3.66 3/31/20231,140,000 shares $3.96 million +3.6%3.3%6.3 $3.47 3/15/20231,100,000 shares $4.38 million -1.8%3.2%7.5 $3.98 2/28/20231,120,000 shares $4.59 million -21.1%3.3%7.5 $4.10 2/15/20231,420,000 shares $6.38 million No Change4.1%9.1 $4.49 1/31/20231,420,000 shares $6.86 million -7.2%4.1%8.7 $4.83 1/15/20231,530,000 shares $6.35 million +1.3%4.5%10.3 $4.15 12/30/20221,510,000 shares $3.70 million -5.6%4.4%12.5 $2.45 12/15/20221,600,000 shares $3.92 million +1.3%4.7%12.3 $2.45 11/30/20221,580,000 shares $4.53 million -3.1%4.6%10.7 $2.87 11/15/20221,630,000 shares $5.22 million +4.5%4.7%10.2 $3.20 10/31/20221,560,000 shares $5.87 million +3.3%4.5%8 $3.76 10/15/20221,510,000 shares $4.32 million -3.2%4.4%7.3 $2.86 9/30/20221,560,000 shares $4.31 million -7.1%4.5%4.7 $2.76 9/15/20221,680,000 shares $6.89 million -6.2%4.9%4.2 $4.10He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs OLMA Short Interest - Frequently Asked Questions What is Olema Pharmaceuticals' current short interest? Short interest is the volume of Olema Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 8,400,000 shares of OLMA short. Learn More on Olema Pharmaceuticals' current short interest. What is a good short interest ratio for Olema Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OLMA shares currently have a short interest ratio of 10.0. Learn More on Olema Pharmaceuticals's short interest ratio. Which institutional investors are shorting Olema Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Olema Pharmaceuticals: Walleye Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Olema Pharmaceuticals' short interest increasing or decreasing? Olema Pharmaceuticals saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 8,400,000 shares, a decline of 6.4% from the previous total of 8,970,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Olema Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Olema Pharmaceuticals: Harrow, Inc. (15.55%), COMPASS Pathways plc (4.99%), SIGA Technologies, Inc. (13.53%), Altimmune, Inc. (31.47%), Avid Bioservices, Inc. (17.42%), IGM Biosciences, Inc. (29.87%), Arbutus Biopharma Co. (3.08%), Aerovate Therapeutics, Inc. (10.43%), Stoke Therapeutics, Inc. (15.94%), Y-mAbs Therapeutics, Inc. (7.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Olema Pharmaceuticals stock? Short selling OLMA is an investing strategy that aims to generate trading profit from Olema Pharmaceuticals as its price is falling. OLMA shares are trading up $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Olema Pharmaceuticals? A short squeeze for Olema Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OLMA, which in turn drives the price of the stock up even further. How often is Olema Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OLMA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: HROW Short Squeeze CMPS Short Squeeze SIGA Short Squeeze ALT Short Squeeze CDMO Short Squeeze IGMS Short Squeeze ABUS Short Squeeze AVTE Short Squeeze STOK Short Squeeze YMAB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OLMA) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits